Having trouble accessing articles? Reset your cache.

Isopropyl unoprostone: Additional Phase II data

Additional data from a double-blind, Japanese Phase II trial in 112 patients showed that twice-daily 2-drop per 5-minute interval dosing of a 0.15% formulation of UF-021 met the secondary endpoint of significantly improving retinal sensitivity from baseline to week 24

Read the full 403 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers